LMAT Lemaitre Vascular PE ratio, current and historical analysis
As of Feb 21, 2025, the Lemaitre Vascular stock's price-to-earnings ratio is 53.52. This results from the current EPS of $1.86 and stock price of $99.54. The PE ratio has increased by 17% from the past four quarters average of 45.9.
LMAT PE ratio history
The PE ratio of Lemaitre Vascular has averaged 38.65 over the last ten years. The current price-to-earnings ratio of 53.52 is 38% more than the historical average. In the past ten years, LMAT's PE ratio reached its highest point in the Jun 2023 quarter at 59.02, when the stock price was $67.28 and the EPS was $1.14. The lowest point was recorded in the Dec 2018 quarter, when it reached 20.03 with a price of $23.64 and an EPS of $1.18.
Lemaitre Vascular PE ratio by year
Maximum annual increase: 137.32% in 2011
Maximum annual decrease: -64.36% in 2010
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2023 | 41.74 | -14.75% | $56.76 | $1.36 |
| 2022 | 48.96 | 23.79% | $46.02 | $0.94 |
| 2021 | 39.55 | 2.54% | $50.23 | $1.27 |
| 2020 | 38.57 | -2.38% | $40.5 | $1.05 |
| 2019 | 39.51 | 97.25% | $35.95 | $0.91 |
| 2018 | 20.03 | -42.76% | $23.64 | $1.18 |
| 2017 | 34.99 | -21.3% | $31.84 | $0.91 |
| 2016 | 44.46 | 13.42% | $25.34 | $0.57 |
| 2015 | 39.2 | 22.96% | $17.25 | $0.44 |
| 2014 | 31.88 | -16.41% | $7.65 | $0.24 |
| 2013 | 38.14 | 12.97% | $8.01 | $0.21 |
| 2012 | 33.76 | -20.17% | $5.74 | $0.17 |
| 2011 | 42.29 | 137.32% | $5.92 | $0.14 |
| 2010 | 17.82 | -64.36% | $6.77 | $0.38 |
| 2009 | 50 | N/A | $5 | $0.1 |
Lemaitre Vascular PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Sep 2024 | 49.94 | 3.18% | $92.89 | $1.86 |
| Jun 2024 | 48.4 | 11.6% | $82.28 | $1.7 |
| Mar 2024 | 43.37 | 3.91% | $66.36 | $1.53 |
| Dec 2023 | 41.74 | -5.76% | $56.76 | $1.36 |
| Sep 2023 | 44.29 | -24.96% | $54.48 | $1.23 |
| Jun 2023 | 59.02 | 7.78% | $67.28 | $1.14 |
| Mar 2023 | 54.76 | 11.85% | $51.47 | $0.94 |
| Dec 2022 | 48.96 | -6.3% | $46.02 | $0.94 |
| Sep 2022 | 52.25 | 17% | $50.68 | $0.97 |
| Jun 2022 | 44.66 | 21.1% | $45.55 | $1.02 |
| Mar 2022 | 36.88 | -6.75% | $46.47 | $1.26 |
| Dec 2021 | 39.55 | -0.18% | $50.23 | $1.27 |
| Sep 2021 | 39.62 | -8.46% | $53.09 | $1.34 |
| Jun 2021 | 43.28 | 4.69% | $61.02 | $1.41 |
| Mar 2021 | 41.34 | 7.18% | $48.78 | $1.18 |
LMAT average PE ratio chart
Currently, LMAT's PE ratio is above its 3, 5 and 10-year historical averages.
LMAT PE vs peers
LMAT's PE ratio is less than its peer stocks BSX and BAX, but it is above EW's and TFX's.
| Stock name | PE ratio | Market cap |
|---|---|---|
| EW Edwards Lifesciences Corp | 10.56 | $43.23B |
| TFX Teleflex Inc | 34.71 | $8.16B |
| LMAT Lemaitre Vascular Inc | 53.52 | $2.24B |
| BSX Boston Scientific Corp | 82.93 | $154.2B |
| ANGO Angiodynamics Inc | N/A | $418.01M |
| BAX Baxter International Inc | N/A | $17.3B |
Frequently asked questions
What is Lemaitre Vascular's PE ratio?
LMAT stock has a price to earnings ratio of 53.52 as of Feb 21, 2025.
What is the 3-year average PE ratio for Lemaitre Vascular (LMAT)?
The average PE ratio for LMAT stock over the past 3 years is 47.66.
What is the 5-year average PE ratio for Lemaitre Vascular (LMAT)?
The average PE ratio for LMAT stock over the past 5 years is 43.27.
What is the highest PE ratio for LMAT?
Over the last ten years, the quarterly PE ratio reached a historic high of 59.02 in the Jun 2023 quarter.
How does the current PE ratio for LMAT compare to its historical average?
LMAT's price to earnings ratio is currently 38% above its 10-year historical average.
How is LMAT's PE ratio calculated (Lemaitre Vascular PE ratio formula)?
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months earnings per share(EPS). As of today (Feb 21, 2025), Lemaitre Vascular's stock price is $99.54. The earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $1.86. Therefore, Lemaitre Vascular's price to earnings ratio for today is 53.52. PE RATIO(53.52) = STOCK PRICE($99.54) / TTM EPS($1.86)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.